Below, we take a look at the rich heiress’ lifestyle, from her family and education, to her achievements and involvement in the arts.
Xie’s family is not only incredibly wealthy but also has an illustrious history. The Charoen Pokphand Group (CP Group), founded in Thailand in 1921, is one of the world’s biggest multinational conglomerates today, controlling more than 400 companies in over 20 countries.
Xie’s grand-uncle, Dhanin Chearavanont, is senior chairman of the CP Group and was once the richest man in Thailand. In 2017, the Chearavanont family was ranked by Forbes Asia as Asia’s fourth-wealthiest family with a total net worth of US$36.6 billion. Xie’s father’s, Xie Zhengmin, is a multi-billionaire, as is her uncle, Xi Guomin.
In an interview with Nebular in 2018, she said, “I regret not studying for a second degree. After working, I realised there is too much to learn. The pharmaceutical industry is very technically demanding. Thinking back, it would have helped my job a lot if I had studied for a technically focused degree.”
At the tender age of 23, she inherited her father’s position and became the chairperson of Chinese Biological Pharmaceutical Co. Ltd.
Despite initial doubts about her abilities, young age and relative lack of experience, she achieved US$1.87 billion in sales in the six months after taking over the company. Within five years, she had successfully increased the company’s market value from US$5 billion to over US$18 billion.
Source: SCMP
No comments:
Post a Comment